Physician profile
Warren Wulff
NPI 1396702023
$5,968.13
in general payments reported to CMS, 2019-2025
16 companies · $1,448 in 2025
The $1,448 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $225 · 2021: $412 · 2022: $455 · 2023: $548 · 2024: $2,102 · 2025: $1,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,146 · Travel and Lodging: $1,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,145.63 |
| Travel and Lodging | $1,952.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,354.17 | 2019-2025 | Proclaim, Eterna |
| Globus Medical, INC. | $711.96 | 2023-2025 | Excelsiusgps Robotic Navigation System, Hedron Ia, Excelsius Gps |
| Medtronic, INC. | $465.29 | 2022-2025 | Mazor X System, Catalyft Pl Expandable Interbody System, Prestige LP Cervical Disc System |
| Intrinsic Therapeutics | $418.28 | 2022-2024 | Barricaid Acd (Annular Closure Device) |
| Stryker Corporation | $325.70 | 2021-2022 | |
| Nevro Corp. | $320.12 | 2019-2024 | Senza |
| Surgalign Spine Technologies, INC. | $317.60 | 2019-2022 | |
| Boston Scientific Corporation | $313.16 | 2019-2022 | |
| Medtronic USA, INC. | $225.03 | 2019 | |
| Saluda Medical Americas, INC. | $150.32 | 2025 | Evoke |
| Alphatec Spine, INC | $140.44 | 2021-2022 | |
| Smith+Nephew, INC. | $90.16 | 2023 | Evos |
| Depuy Synthes Sales INC. | $78.99 | 2019-2022 | |
| Si-Bone, INC. | $22.88 | 2022 | |
| Cerapedics INC. | $18.73 | 2024 | I-Factor Peptide Enhanced Bone Graft |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $15.30 | 2024 | Elan 4 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Wulff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.